Prostatis Group LLC Illumina, Inc. Transaction History

Prostatis Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 23, 2023	SELL	$347.28 - $421.83 $3.52 Million - $4.28 Million	-10,140 Closed	0 $0
Q3 2021 Mar 23, 2023	SELL	$405.61 - $524.84 $685,480 - $886,979	-1,690 Reduced 14.29%	10,140 $10.1 Million
Q2 2021 Mar 23, 2023	BUY	$372.84 - $481.5 $4.41 Million - $5.7 Million	11,830 New	11,830 $11.8 Million
Q2 2020 Mar 23, 2023	SELL	$256.46 - $373.01 $24.6 Million - $35.8 Million	-95,866 Closed	0 $0
Q1 2020 Mar 23, 2023	BUY	$209.2 - $335.53 $20.1 Million - $32.2 Million	95,866 New	95,866 $94.8 Million

904

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.1B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prostatis Group LLC with notifications on news.